IRIS Accounts Production v25.2.0.378 08934536 director 1.4.24 31.3.25 31.3.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh089345362024-03-31089345362025-03-31089345362024-04-012025-03-31089345362023-03-31089345362023-04-012024-03-31089345362024-03-3108934536ns15:EnglandWales2024-04-012025-03-3108934536ns14:PoundSterling2024-04-012025-03-3108934536ns10:Director12024-04-012025-03-3108934536ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3108934536ns10:SmallEntities2024-04-012025-03-3108934536ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3108934536ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3108934536ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3108934536ns10:FullAccounts2024-04-012025-03-310893453612024-04-012025-03-3108934536ns10:CompanySecretary12024-04-012025-03-3108934536ns10:RegisteredOffice2024-04-012025-03-3108934536ns5:CurrentFinancialInstruments2025-03-3108934536ns5:CurrentFinancialInstruments2024-03-3108934536ns5:ShareCapital2025-03-3108934536ns5:ShareCapital2024-03-3108934536ns5:RetainedEarningsAccumulatedLosses2025-03-3108934536ns5:RetainedEarningsAccumulatedLosses2024-03-3108934536ns5:NetGoodwill2024-04-012025-03-3108934536ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108934536ns5:LandBuildingsns5:ShortLeaseholdAssets2024-04-012025-03-3108934536ns5:PlantMachinery2024-04-012025-03-3108934536ns5:FurnitureFittings2024-04-012025-03-3108934536ns5:NetGoodwill2024-03-3108934536ns5:NetGoodwill2025-03-3108934536ns5:NetGoodwill2024-03-3108934536ns5:LandBuildingsns5:ShortLeaseholdAssets2024-03-3108934536ns5:PlantMachinery2024-03-3108934536ns5:FurnitureFittings2024-03-3108934536ns5:LandBuildingsns5:ShortLeaseholdAssets2025-03-3108934536ns5:PlantMachinery2025-03-3108934536ns5:FurnitureFittings2025-03-3108934536ns5:LandBuildingsns5:ShortLeaseholdAssets2024-03-3108934536ns5:PlantMachinery2024-03-3108934536ns5:FurnitureFittings2024-03-3108934536ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3108934536ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3108934536ns5:WithinOneYear2025-03-3108934536ns5:WithinOneYear2024-03-3108934536ns5:BetweenOneFiveYears2025-03-3108934536ns5:BetweenOneFiveYears2024-03-3108934536ns5:MoreThanFiveYears2025-03-3108934536ns5:MoreThanFiveYears2024-03-3108934536ns5:AllPeriods2025-03-3108934536ns5:AllPeriods2024-03-31
REGISTERED NUMBER: 08934536 (England and Wales)















LEYES LANE PHARMACY LIMITED

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025






LEYES LANE PHARMACY LIMITED (REGISTERED NUMBER: 08934536)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


LEYES LANE PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTOR: Mrs C A Harvey





SECRETARY: G M Harvey





REGISTERED OFFICE: Leyes Lane Pharmacy Ltd
35 Leyes Lane
Kenilworth
Warwickshire
CV8 2DE





REGISTERED NUMBER: 08934536 (England and Wales)





ACCOUNTANTS: Sephton & Company LLP
Chartered Certified Accountants
Marston House
5 Elmdon Lane
Marston Green
Solihull
West Midlands
B37 7DL

LEYES LANE PHARMACY LIMITED (REGISTERED NUMBER: 08934536)

BALANCE SHEET
31 MARCH 2025

31/3/25 31/3/24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 15,661 19,661
Tangible assets 5 37,052 41,474
52,713 61,135

CURRENT ASSETS
Stocks 30,603 35,742
Debtors 6 62,143 37,390
Cash at bank and in hand 212,043 262,850
304,789 335,982
CREDITORS
Amounts falling due within one year 7 147,913 168,653
NET CURRENT ASSETS 156,876 167,329
TOTAL ASSETS LESS CURRENT
LIABILITIES

209,589

228,464

PROVISIONS FOR LIABILITIES 6,623 7,223
NET ASSETS 202,966 221,241

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 202,866 221,141
SHAREHOLDERS' FUNDS 202,966 221,241

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

LEYES LANE PHARMACY LIMITED (REGISTERED NUMBER: 08934536)

BALANCE SHEET - continued
31 MARCH 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 1 August 2025 and were signed by:





Mrs C A Harvey - Director


LEYES LANE PHARMACY LIMITED (REGISTERED NUMBER: 08934536)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

Leyes Lane Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2014, is being amortised evenly over its estimated useful life of fifteen years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Short leasehold - straight line over 18 years
Plant and machinery - 20% on reducing balance
Fixtures and fittings - 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


LEYES LANE PHARMACY LIMITED (REGISTERED NUMBER: 08934536)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2024 - 10 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2024
and 31 March 2025 60,000
AMORTISATION
At 1 April 2024 40,339
Charge for year 4,000
At 31 March 2025 44,339
NET BOOK VALUE
At 31 March 2025 15,661
At 31 March 2024 19,661

LEYES LANE PHARMACY LIMITED (REGISTERED NUMBER: 08934536)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


5. TANGIBLE FIXED ASSETS
Fixtures
Short Plant and and
leasehold machinery fittings Totals
£    £    £    £   
COST
At 1 April 2024 30,241 7,898 54,243 92,382
Additions - - 4,650 4,650
At 31 March 2025 30,241 7,898 58,893 97,032
DEPRECIATION
At 1 April 2024 18,918 7,039 24,951 50,908
Charge for year 1,945 341 6,786 9,072
At 31 March 2025 20,863 7,380 31,737 59,980
NET BOOK VALUE
At 31 March 2025 9,378 518 27,156 37,052
At 31 March 2024 11,323 859 29,292 41,474

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/3/25 31/3/24
£    £   
Trade debtors 24,287 -
Other debtors 37,856 37,390
62,143 37,390

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/3/25 31/3/24
£    £   
Trade creditors 129,763 147,505
Taxation and social security 15,158 17,637
Other creditors 2,992 3,511
147,913 168,653

8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
31/3/25 31/3/24
£    £   
Within one year 16,750 16,750
Between one and five years 60,021 67,000
In more than five years - 9,771
76,771 93,521